-+ 0.00%
-+ 0.00%
-+ 0.00%

ARBELE RECEIVES FDA ORPHAN DRUG DESIGNATION FOR ARB1002, AN ANTI-CDH17 ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF PANCREATIC CANCER

路透·01/07/2026 16:00:17

登錄查看新聞詳情